ID   SK-RC-52
AC   CVCL_6198
SY   SK-RC 52; SK RC 52; SKRC-52
DR   cancercelllines; CVCL_6198
DR   Cosmic; 945061
DR   GEO; GSM374466
DR   Progenetix; CVCL_6198
DR   Wikidata; Q54954600
RX   PubMed=2386958;
RX   PubMed=27993170;
WW   Provider; MSKCC; -; https://www.mskcc.org/research-advantage/support/technology/tangible-material/sk-rc-m-metastatic-human-renal-cell-carcinoma-rcc-cell-line-collection
CC   From: Memorial Sloan Kettering Cancer Center; New York; USA.
CC   Doubling time: 36 hours (PubMed=2386958).
CC   Miscellaneous: STR profile and age/sex of donor from MSKCC antibody and bioresource core facility.
CC   Derived from site: Metastatic; Mediastinum; UBERON=UBERON_0003728.
ST   Source(s): MSKCC
ST   Amelogenin: X
ST   CSF1PO: 12
ST   D13S317: 8
ST   D16S539: 10,13
ST   D18S51: 15
ST   D19S433: 15,15.2
ST   D21S11: 30,32.2
ST   D2S1338: 20
ST   D3S1358: 16
ST   D5S818: 11,12
ST   D7S820: 9,12
ST   D8S1179: 13,16
ST   FGA: 23,24
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 16
DI   NCIt; C9385; Renal cell carcinoma
DI   ORDO; Orphanet_217071; Renal cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   61Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 23
//
RX   PubMed=2386958;
RA   Ebert T., Bander N.H., Finstad C.L., Ramsawak R.D., Old L.J.;
RT   "Establishment and characterization of human renal cancer and normal
RT   kidney cell lines.";
RL   Cancer Res. 50:5531-5536(1990).
//
RX   PubMed=27993170; DOI=10.1186/s12943-016-0565-8; PMCID=PMC5168717;
RA   Brodaczewska K.K., Szczylik C., Fiedorowicz M., Porta C.,
RA   Czarnecka A.M.;
RT   "Choosing the right cell line for renal cell cancer research.";
RL   Mol. Cancer 15:83.1-83.15(2016).
//